Desmoteplase for Acute Ischemic Stroke within 3 to 9 Hours after Symptom Onset: Evidence from Randomized Controlled Trials

Recent studies have shown inconsistent results regarding the value of desmoteplase for treating acute ischemic stroke (AIS) when administered within an extended time window. We performed a meta-analysis to explore the value of desmoteplase in AIS treatment. The MEDLINE, EMBASE, and Cochrane Library...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Sci Rep
Huvudupphovsmän: Shi, Ligen, Liang, Feng, Li, Yunping, Shao, Anwen, Zhou, Keren, Yu, Jun, Zhang, Jianmin
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5037417/
https://ncbi.nlm.nih.gov/pubmed/27671010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep33989
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk